Evidence map›Paper›PMID 29445111›Full record

ArticleScientific reports2018

Fluvastatin protects cochleae from damage by high-level noise.

Claus-Peter Richter, Hunter Young, Sonja V Richter, Virginia Smith-Bronstein, Stuart R Stock, Xianghui Xiao, Carmen Soriano, Donna S Whitlon

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06729632 (Non-Invasive System to Deliver Therapeutic Hypothermia for Protection Against Noise-Induced Hearing Loss), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06729632 narecruitingnot on this mapstarted 2024, after this paper: background citation

Non-Invasive System to Deliver Therapeutic Hypothermia for Protection Against Noise-Induced Hearing Loss

TypeinterventionalSponsorRestorear Devices LLCRan2024 to 2027Enrolled116ConditionsNoise Exposure, Noise-induced Hearing Loss, Noise, Adverse EffectArmsCold pack-delivered mild therapeutic hypothermia
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Claus-Peter RichterDepartment of Otolaryngology, Northwestern University Feinberg School of Medicine, Chicago, United States of America.ORCID 0000-0002-1423-4751
Hunter YoungDepartment of Otolaryngology, Northwestern University Feinberg School of Medicine, Chicago, United States of America.
Sonja V RichterDepartment of Otolaryngology, Northwestern University Feinberg School of Medicine, Chicago, United States of America.
Virginia Smith-BronsteinDepartment of Otolaryngology, Northwestern University Feinberg School of Medicine, Chicago, United States of America.
Stuart R StockDepartment of Cell and Molecular Biology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America.
Xianghui XiaoAdvanced Photon Source, Argonne National Laboratory, Argonne, United States of America.
Carmen SorianoAdvanced Photon Source, Argonne National Laboratory, Argonne, United States of America.
Donna S WhitlonDepartment of Otolaryngology, Northwestern University Feinberg School of Medicine, Chicago, United States of America. Whitlon@northwestern.edu.
Northwestern University · USArgonne National Laboratory · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exposure to noise and ototoxic drugs are responsible for much of the debilitating hearing loss experienced by about 350 million people worldwide. Beyond hearing aids and cochlear implants, there have been no other FDA approved drug interventions established in the clinic that would either protect or reverse the effects of hearing loss. Using Auditory Brainstem Responses (ABR) in a guinea pig model, we demonstrate that fluvastatin, an inhibitor of HMG-CoA reductase, the rate-limiting enzyme of the mevalonate pathway, protects against loss of cochlear function initiated by high intensity noise. A novel synchrotron radiation based X-ray tomographic method that imaged soft tissues at micrometer resolution in unsectioned cochleae, allowed an efficient, qualitative evaluation of the three-dimensional internal structure of the intact organ. For quantitative measures, plastic embedded cochleae were sectioned followed by hair cell counting. Protection in noise-exposed cochleae is associated with retention of inner and outer hair cells. This study demonstrates the potential of HMG-CoA reductase inhibitors, already vetted in human medicine for other purposes, to protect against noise induced hearing loss.

Indexed as

AnimalsAuditory ThresholdCochleaEvoked Potentials, Auditory, Brain StemFemaleFluvastatinGuinea PigsHair Cells, Auditory, OuterHearing Loss, Noise-InducedMaleNoiseOrgan of CortiProtective AgentsFluvastatinProtective Agents

Identifiers

PMID29445111
PMCPMC5813011
OpenAlexW2805238715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.